FAMOTIDINE IN ACUTE DUODENAL ULCER

Authors

  • Alamzeb Manan

Abstract

ABSTRACTThis is an 8-week open study in which the effect and tolerance of Famotidine, in a dose of 40mg nocte was tried for the treatment of duodenal ulcer in 22 patients. Assessment was madeclinically, biochemically and endoscopically. The healing rate at the end of 8 weeks was 95.45%.The drug was well tolerated with no significant side effect. In conclusion, Famotidine is an effectiveand safe Duodenal ulcer healing drug, which is well tolerated and has minimal side effects

References

Bonnivie, O. Survival in peptic ulcer, Gastroenterology 1978; 75: 1055-60.

Gough K.R. Korman M.G. Bradham K.D. et al. Ranitadine and Cimetidine in prevention of duodenal

ulcer. Lancet 1989, (No. 2): 659-62.

Smith, J.R., Gamal, M., Chremos., A.N. and Graham D.Y. Famotidine a new H2 receptor antagonist.

Effect on parietal, non-parietal and pepsin secretion in man Dig. dis. sci. 1985; 30: 308)'

Rayan. J.R., Cremus, A.N. and Vargas R. Inhibition of basal nocturnal and mean stimulated acid

secretion by Famotidine Gastroenterology 1985; 88: 1564.

Liang. T. Absence of androgenic receptor affinity for MK-208, a new H2 receptor antagonist Clin.

Res., 18: 105.

Rashid R and Khan M.A, Treatment of acute duodenal ulcer with Famotidine and its comparison

with other H2 receptor antagonists JPMA 1990; 136-7.

Issue

Vol. 4 No. 2 (1991): JOURNAL OF AYUB MEDICAL COLLEGE, ABBOTTABAD

Section

ORIGINAL ARTICLE

License

Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License  CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.

USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.

AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.